Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 19,992 | 12,969 | 65,329 | 938 |
| Marketable Securities | 53,051 | 88,058 | N/A | N/A |
| TOTAL | $73,755 | $101,504 | $65,477 | $938 |
| Non-Current Assets | ||||
| PPE Net | 1,244 | 394 | 12 | N/A |
| Investments And Advances | 4,590 | 0 | 0 | 0 |
| Other Non-Current Assets | 30 | 22 | 0 | 0 |
| TOTAL | $5,864 | $416 | $12 | $N/A |
| Total Assets | $79,619 | $101,920 | $65,489 | $938 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 717 | 420 | 689 | 6 |
| Accrued Expenses | 2,491 | 2,432 | 1,521 | 60 |
| Other current liabilities | N/A | N/A | N/A | 5 |
| TOTAL | $3,208 | $2,852 | $2,210 | $70 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 40 | 44 | 0 | 0 |
| TOTAL | $40 | $44 | $N/A | $N/A |
| Total Liabilities | $3,248 | $2,896 | $2,210 | $70 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 19,836 | 19,724 | N/A | N/A |
| Common Shares | 2 | 2 | 2 | 0 |
| Retained earnings | -58,602 | -31,472 | -4,333 | -120 |
| Other shareholders' equity | -50 | -27 | 0 | 987 |
| TOTAL | $76,371 | $99,024 | $63,279 | $868 |
| Total Liabilities And Equity | $79,619 | $101,920 | $65,489 | $938 |